StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the stock.
China Pharma Stock Performance
NYSE CPHI opened at $0.25 on Thursday. China Pharma has a 52-week low of $0.24 and a 52-week high of $1.77. The business’s 50-day moving average price is $0.27 and its 200 day moving average price is $0.35. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.89 and a quick ratio of 0.25.
China Pharma (NYSE:CPHI – Get Free Report) last posted its quarterly earnings data on Wednesday, May 15th. The company reported ($0.07) earnings per share for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%. The company had revenue of $1.37 million for the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- How to Use Stock Screeners to Find Stocks
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- How to buy stock: A step-by-step guide for beginnersÂ
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Energy and Oil Stocks Explained
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
